It helps to reduce oxidative stress and can help combat a number of diseases, especially those related to aging
this is specifically a concern in fibrosis, wherein ROS pathways are often upregulated 27
Researchers must understand that this compound is investigational and not FDA approved for any medical indication
Of note, dual receptor agonists have significantly advanced incretin-based therapy by concurrently engaging glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors within a single peptide molecule
(PubMed) Iyer RN, Khan AA, Gupta A, Vajifdar BU, Lokhandwala YY
A New Path to a Healthier You Struggling with weight loss can be an isolating and difficult battle, but you don't have to face it alone